Want to see AU:EZZ full AI Analyst Report?
EZZ Stock Chart & Stats
AU$0.64
-AU$0.02(-3.88%)
At close: 4:00 PM EDT
AU$0.64
-AU$0.02(-3.88%)
Day’s Range― - ―
52-Week RangeAU$0.30 - AU$3.20
Previous CloseN/A
Volume16.90K
Average Volume (3M)17.42K
Market Cap
AU$14.35M
Enterprise ValueAU$7.93M
Total Cash (Recent Filing)AU$9.72M
Total Debt (Recent Filing)AU$478.59K
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Mar 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield13.17%
Share Statistics
EPS (TTM)-0.11
Shares Outstanding47,043,200
10 Day Avg. Volume20,004
30 Day Avg. Volume17,419
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.70
Price to Sales (P/S)0.37
P/FCF Ratio-1.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.24
Revenue Forecast (FY)AU$105.10M
Bulls Say, Bears Say
Bulls Say
Very Low LeverageVery low leverage limits debt-related financial risk and gives EZZ greater flexibility while operations are volatile. A sizable equity base can help the company absorb weaker trading conditions and pursue recovery without the immediate pressure of heavy borrowing costs or refinancing obligations.
Healthy Gross Margin And Prior ProfitabilityThe retained gross margin indicates that EZZ still generates meaningful value above product costs despite the latest downturn. Its record of profitability before FY2026 provides evidence of an established earnings model that could support recovery if revenue and cost performance improve.
Own-brand Health Portfolio And Broad ChannelsEZZ combines proprietary health and wellness products with multiple routes to market, including retail, distribution and international e-commerce. This model can support brand development and broaden customer access over time, giving the company several channels through which to rebuild demand.
Bears Say
Sharp Revenue ContractionThe sharp revenue decline signals a material setback in demand, distribution or product performance rather than normal quarterly volatility. Sustained top-line weakness would reduce operating leverage, constrain investment in the product portfolio and make a return to prior growth and profitability more difficult.
Losses And Margin CompressionMoving from prior profitability to a net loss and negative operating profit weakens earnings quality and demonstrates that the current revenue base is not covering the company’s operating structure. Gross-margin compression further reduces the buffer available to restore profits through recovery or reinvestment.
Negative Operating And Free Cash FlowCash consumption alongside a reported loss increases execution risk because the business is not currently funding operations internally. If negative operating and free cash flow persists, EZZ may have less flexibility to invest in growth, maintain distributions or withstand further operating weakness.
EZZ Life Science Holdings Ltd. News
EZZ FAQ
What was EZZ Life Science Holdings Ltd.’s price range in the past 12 months?
EZZ Life Science Holdings Ltd. lowest share price was AU$0.30 and its highest was AU$3.20 in the past 12 months.
What is EZZ Life Science Holdings Ltd.’s market cap?
EZZ Life Science Holdings Ltd.’s market cap is AU$14.35M.
When is EZZ Life Science Holdings Ltd.’s upcoming earnings report date?
EZZ Life Science Holdings Ltd.’s upcoming earnings report date is Mar 01, 2027 which is in 124 days.
How were EZZ Life Science Holdings Ltd.’s earnings last quarter?
EZZ Life Science Holdings Ltd. released its earnings results on Aug 31, 2026. The company reported -AU$0.1 earnings per share for the quarter.
Is EZZ Life Science Holdings Ltd. overvalued?
According to Wall Street analysts EZZ Life Science Holdings Ltd.’s price is currently Overvalued.
Does EZZ Life Science Holdings Ltd. pay dividends?
EZZ Life Science Holdings Ltd. pays a Semiannually dividend of AU$0.02 which represents an annual dividend yield of 13.17%. See more information on EZZ Life Science Holdings Ltd. dividends here
What is EZZ Life Science Holdings Ltd.’s EPS estimate?
EZZ Life Science Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EZZ Life Science Holdings Ltd. have?
EZZ Life Science Holdings Ltd. has 47,043,200 shares outstanding.
What happened to EZZ Life Science Holdings Ltd.’s price movement after its last earnings report?
EZZ Life Science Holdings Ltd. reported an EPS of -AU$0.1 in its last earnings report. Following the earnings report the stock price went down -8.594%.
Which hedge fund is a major shareholder of EZZ Life Science Holdings Ltd.?
Currently, no hedge funds are holding shares in AU:EZZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EZZ Life Science Holdings Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:EZZ Sentiment 100%
Sector Average 66%
Sector Average 66%
Insider Transactions
Sold Shares
Worth AU$14.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.73%
12-Months-Change
Fundamentals
Return on Equity
-20.36%
Trailing 12-Months
Asset Growth
-18.60%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories. The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores. Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines. These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.
Technical Analysis
Zelira Therapeutics
―
Immuron Limited
―
Anatara Lifesciences Ltd
―
Botanix Pharmaceuticals Limited
―
Biome Australia Ltd
―